144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797630718224891904 |
|---|---|
| author | Gary Chan Hideho Okada Kaori Okada Iñaki Etxeberría Christopher A Klebanoff Joseph Costello Takahide Nejo James Woo Akane Yamamichi Darwin Kwok Chibo Hong Aidan Du Nicholas Stevers Senthilnath Lakshmanachetty Jangham Jung Lee Chen Marco Gallus Emilio Ramos Maggie Colton Cove Arun Wiita |
| author_facet | Gary Chan Hideho Okada Kaori Okada Iñaki Etxeberría Christopher A Klebanoff Joseph Costello Takahide Nejo James Woo Akane Yamamichi Darwin Kwok Chibo Hong Aidan Du Nicholas Stevers Senthilnath Lakshmanachetty Jangham Jung Lee Chen Marco Gallus Emilio Ramos Maggie Colton Cove Arun Wiita |
| author_sort | Gary Chan |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:12:05Z |
| format | Article |
| id | doaj.art-fec823ec6d40440596000f041a7169b0 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:12:05Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-fec823ec6d40440596000f041a7169b02023-11-12T03:25:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0144144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer typesGary Chan0Hideho Okada1Kaori Okada2Iñaki Etxeberría3Christopher A Klebanoff4Joseph Costello5Takahide Nejo6James Woo7Akane Yamamichi8Darwin Kwok9Chibo Hong10Aidan Du11Nicholas Stevers12Senthilnath Lakshmanachetty13Jangham Jung14Lee Chen15Marco Gallus16Emilio Ramos17Maggie Colton Cove18Arun Wiita1910Pfizer Inc, Collegeville, Pennsylvania, USA1University of California, San Francisco, San Francisco, CA, USAAff310 grid.266102.10000000122976811University of California, San Francisco San Francisco CA USAProgram of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Navarra, SpainMemorial Sloan Kettering Cancer Center, New York, NY, USA1University of California, San Francisco, San Francisco, CA, USA1University of California San Francisco, San Francisco, CA, USAUniversity of California San Francisco, San Francisco, CA, USADepartment of Neurology, UCSF, San Francisco, California, USA1University of California, San Francisco, San Francisco, CA, USA1University of California San Francisco (UCSF), San Francisco, CA, USAUniversity of California San Francisco, San Francisco, CA, USA1University of California, San Francisco, San Francisco, CA, USA1University of California, San Francisco, San Francisco, CA, USA1University of California San Francisco (UCSF), San Francisco, CA, USA1University of California San Francisco (UCSF), San Francisco, CA, USA1University of California San Francisco (UCSF), San Francisco, CA, USA1University of California San Francisco (UCSF), San Francisco, CA, USA1University of California San Francisco (UCSF), San Francisco, CA, USA1University of California San Francisco (UCSF), San Francisco, CA, USA |
| spellingShingle | Gary Chan Hideho Okada Kaori Okada Iñaki Etxeberría Christopher A Klebanoff Joseph Costello Takahide Nejo James Woo Akane Yamamichi Darwin Kwok Chibo Hong Aidan Du Nicholas Stevers Senthilnath Lakshmanachetty Jangham Jung Lee Chen Marco Gallus Emilio Ramos Maggie Colton Cove Arun Wiita 144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types Journal for ImmunoTherapy of Cancer |
| title | 144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types |
| title_full | 144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types |
| title_fullStr | 144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types |
| title_full_unstemmed | 144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types |
| title_short | 144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types |
| title_sort | 144 novel public and tumor wide neoantigens arising from clonal aberrant splicing events drive tumor specific t cell responses across diverse cancer types |
| work_keys_str_mv | AT garychan 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT hidehookada 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT kaoriokada 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT inakietxeberria 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT christopheraklebanoff 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT josephcostello 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT takahidenejo 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT jameswoo 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT akaneyamamichi 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT darwinkwok 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT chibohong 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT aidandu 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT nicholasstevers 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT senthilnathlakshmanachetty 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT janghamjung 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT leechen 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT marcogallus 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT emilioramos 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT maggiecoltoncove 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes AT arunwiita 144novelpublicandtumorwideneoantigensarisingfromclonalaberrantsplicingeventsdrivetumorspecifictcellresponsesacrossdiversecancertypes |